Cell-based assays coupled with gene-specific shRNA silencing confirmed that VTD was sufficient to induce UBXN2A protein levels, resulting in colon cancer cell death in UBXN2A- and mot-2-dependent manners. The gene discussed is UBXN2A; the disease is colonic neoplasm.